Affirmers17 Jul 2020 15:04
very important note as I was perusing the Avacta website:
Intellectual Property
Avacta® has exclusive rights over the Affimer® technology intellectual property through a number of granted global patents and patents pending. The company continues to broaden its Affimer® platform intellectual property, as well as generating application specific know-how and patentable inventions, through active R&D programmes.
This simple intellectual property position, in addition to the company’s unique know-how and experience of the Affimer® technology, lies at the core of our arrangements to develop innovative therapeutics, research tools and diagnostics.
As there is an Affirmer for everything then the future is very bright, this tech is being proven across multiple applications